Latest News in the pharma Industry

Research & Development

Pfizer and BioNTech to supply Japan with 120 million doses of mRNA-based vaccine candidate

Pfizer and BioNTech to supply Japan with 120 million doses of mRNA-based vaccine candidate

3 Aug 2020

The companies are set to manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021.

Read more 
Construction underway on new Croda North American HQ and Innovation Centre

Construction underway on new Croda North American HQ and Innovation Centre

28 Jul 2020

The facility will support the company'a goal of being climate, land and people positive by 2030.

Read more 
Vital Signs Solutions receives backing to facilitate mass-scale antibody testing for COVID-19

Vital Signs Solutions receives backing to facilitate mass-scale antibody testing for COVID-19

27 Jul 2020

The company will adapt its digital platform to digitize any COVID-19 antibody rapid test assay and embed this within an app available on smartphones and tablets.

Read more 
Stevanato Group and Colanar colaborate to study container closure systems

Stevanato Group and Colanar colaborate to study container closure systems

21 Jul 2020

The data generated through the partnership will help biopharma companies to develop robust manufacturing processes and minimize challenges during scale-up and commercialization.

Read more 
Colorcon launches new enteric coating with pH up to 5.0

Colorcon launches new enteric coating with pH up to 5.0

20 Jul 2020

Acryl-EZE formulations provide significant time savings and targeted drug delivery.

Read more 
Humanigen expands partnership with Catalent to manufacture investigational COVID-19 therapeutic candidate

Humanigen expands partnership with Catalent to manufacture investigational COVID-19 therapeutic candidate

20 Jul 2020

Data on the first clinical use of lenzilumab in patients with severe COVID-19 pneumonia suggest promising results.

Read more 
Arctoris supports global research efforts to find new therapeutics against COVID-19

Arctoris supports global research efforts to find new therapeutics against COVID-19

14 Jul 2020

The company is also involved in projects that aim to enable population-level screening for the current coronavirus.

Read more 
Cobra Biologics delivers final plasmids for CombiGene's epilepsy project

Cobra Biologics delivers final plasmids for CombiGene's epilepsy project

13 Jul 2020

Further milestone paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.

Read more 
Merck KGaA opens its largest M Lab Collaboration Center in Shanghai

Merck KGaA opens its largest M Lab Collaboration Center in Shanghai

13 Jul 2020

The center will host a new BioReliance End-to-End Solutions GMP manufacturing facility offering CDMO services to customers in China and Asia-Pacific.

Read more 
Vetter further expands its development service with new site in Austria

Vetter further expands its development service with new site in Austria

13 Jul 2020

The CDMO responds to the growing demand for complex fill and finish solutions.

Read more 
Regeneron wins $450 million US government manufacturing agreement for anti-viral antibody cocktail

Regeneron wins $450 million US government manufacturing agreement for anti-viral antibody cocktail

7 Jul 2020

The company began scaling up manufacturing of REGN-COV2 at business risk earlier this year to ensure the immediate availability of the product if clinical trials prove successful.

Read more 
SGS joins with Biophytis to launch international trial of COVID-19 related respiratory failure treatment

SGS joins with Biophytis to launch international trial of COVID-19 related respiratory failure treatment

7 Jul 2020

The CRO will undertake this clinical trial at multiple sites worldwide, starting at the AZ Sint Maarten hospital in Mechelen, Belgium.

Read more